X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (43053) 43053
Newsletter (16842) 16842
Book Review (7882) 7882
Publication (2410) 2410
Newspaper Article (2195) 2195
Book Chapter (265) 265
Conference Proceeding (150) 150
Transcript (146) 146
Magazine Article (114) 114
Reference (52) 52
Book / eBook (37) 37
Trade Publication Article (29) 29
Dissertation (24) 24
Web Resource (11) 11
Journal / eJournal (4) 4
Paper (3) 3
Streaming Video (3) 3
Government Document (2) 2
Data Set (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
non-hodgkin's lymphomas (30239) 30239
index medicus (29548) 29548
humans (28614) 28614
non-hodgkins-lymphoma (16158) 16158
male (15648) 15648
cancer (15368) 15368
female (15148) 15148
oncology (13911) 13911
middle aged (12963) 12963
research (12652) 12652
adult (11414) 11414
aged (10658) 10658
t cells (10112) 10112
hematology (9928) 9928
care and treatment (8852) 8852
chemotherapy (7955) 7955
lymphomas (7680) 7680
prognosis (6168) 6168
reports (5953) 5953
lymphoma (5468) 5468
non-hodgkin's lymphoma (5299) 5299
medical research (4722) 4722
antineoplastic combined chemotherapy protocols - therapeutic use (4486) 4486
aged, 80 and over (4345) 4345
adolescent (4297) 4297
medicine, experimental (4249) 4249
treatment outcome (4146) 4146
health aspects (4016) 4016
analysis (3972) 3972
rituximab (3968) 3968
universities and colleges (3918) 3918
risk factors (3833) 3833
leukemia (3760) 3760
non-hodgkin lymphoma (3659) 3659
b-cell lymphoma (3631) 3631
transplantation (3364) 3364
pathology (3324) 3324
diagnosis (3297) 3297
retrospective studies (3274) 3274
non-hodgkin-lymphoma (3209) 3209
genetic aspects (3195) 3195
drug therapy (3105) 3105
animals (3095) 3095
abridged index medicus (3088) 3088
therapy (2871) 2871
antineoplastic agents (2812) 2812
disease (2786) 2786
lymphoma, non-hodgkin - pathology (2745) 2745
antimitotic agents (2715) 2715
oncology, experimental (2651) 2651
child (2645) 2645
tumors (2632) 2632
immunohistochemistry (2489) 2489
lymphoma, non-hodgkin - drug therapy (2403) 2403
chronic lymphocytic-leukemia (2399) 2399
immunology (2365) 2365
survival (2330) 2330
follicular lymphoma (2211) 2211
expression (2207) 2207
hemic and lymphatic diseases (2152) 2152
antineoplastic agents - therapeutic use (2135) 2135
neoplasm staging (2128) 2128
medicine & public health (2109) 2109
immunotherapy (2072) 2072
young adult (2037) 2037
non-hodgkins-lymphomas (2029) 2029
malignant-lymphoma (2012) 2012
disease-free survival (1977) 1977
survival rate (1960) 1960
apoptosis (1954) 1954
classification (1949) 1949
combined modality therapy (1930) 1930
clinical trials (1909) 1909
stem cells (1895) 1895
survival analysis (1882) 1882
radiotherapy (1821) 1821
pharmaceutical industry (1817) 1817
cyclophosphamide - administration & dosage (1816) 1816
risk (1744) 1744
follow-up studies (1734) 1734
lymphoma, large b-cell, diffuse - pathology (1730) 1730
physical fitness (1667) 1667
development and progression (1651) 1651
epidemiology (1646) 1646
medicine, general & internal (1643) 1643
radiology, nuclear medicine & medical imaging (1612) 1612
lymphoma, non-hodgkin - therapy (1576) 1576
cell research (1574) 1574
vincristine - administration & dosage (1541) 1541
child, preschool (1514) 1514
lymphoma, b-cell - pathology (1510) 1510
doxorubicin - administration & dosage (1484) 1484
lymphoma, large b-cell, diffuse - drug therapy (1454) 1454
monoclonal antibodies (1447) 1447
surgery (1447) 1447
mice (1433) 1433
antineoplastic combined chemotherapy protocols - administration & dosage (1411) 1411
diagnosis, differential (1404) 1404
cyclophosphamide (1398) 1398
antibodies, monoclonal - therapeutic use (1396) 1396
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (8) 8
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (7) 7
Robarts - Stacks (2) 2
Collection Dvlpm't (Acquisitions) - Closed Orders (1) 1
Online Resources - Online (1) 1
Scarborough Hospital - General (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (59682) 59682
Japanese (999) 999
Chinese (541) 541
French (488) 488
German (458) 458
Spanish (232) 232
Russian (131) 131
Polish (72) 72
Czech (29) 29
Portuguese (25) 25
Korean (19) 19
Hungarian (16) 16
Italian (13) 13
Turkish (10) 10
Persian (7) 7
Slovak (3) 3
Slovenian (3) 3
Croatian (2) 2
Dutch (2) 2
Serbian (2) 2
Swedish (2) 2
Greek (1) 1
Latvian (1) 1
Manx (1) 1
Thai (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


BLOOD, ISSN 0006-4971, 11/2007, Volume 110, Issue 9, pp. 3281 - 3290
The proteasome has emerged as an important target for cancer therapy with the approval of bortezomib, a first-in-class, reversible proteasome inhibitor, for... 
CYTOCHROME-C | PEGYLATED LIPOSOMAL DOXORUBICIN | CELLS | APOPTOSIS | CHEMOTHERAPEUTIC-AGENTS | PHASE-I TRIAL | NON-HODGKINS-LYMPHOMA | BORTEZOMIB | PS-341 | HEMATOLOGY | HEMATOLOGIC MALIGNANCIES
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2015, Volume 33, Issue 14, pp. 1625 - 1625
Journal Article
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 09/2013, Volume 31, Issue 26, pp. 3272 - 3278
Purpose This study sought to characterize transformation incidence and outcome for patients with follicular lymphoma (FL) in a prospective observational series... 
SURVIVAL | DIAGNOSIS | ONCOLOGY | REFRACTORY LOW-GRADE | HIGH-DOSE THERAPY | RITUXIMAB | NON-HODGKINS-LYMPHOMA | I-131 TOSITUMOMAB | INDOLENT | HISTOLOGICAL TRANSFORMATION | CHEMOTHERAPY | ORIGINAL REPORTS | Hema10
Journal Article
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, ISSN 0027-8874, 05/2018, Volume 110, Issue 5, pp. 509 - 516
Background: Glyphosate is the most commonly used herbicide worldwide, with both residential and agricultural uses. In 2015, the International Agency for... 
MULTIPLE-MYELOMA | IOWA | RISK-FACTOR | ONCOLOGY | PESTICIDE EXPOSURES | MEN | NON-HODGKINS-LYMPHOMA | LEUKEMIA | OCCUPATIONAL-EXPOSURE | APPLICATORS
Journal Article
Pathology International, ISSN 1320-5463, 05/2019, Volume 69, Issue 5, pp. 312 - 314
Journal Article
BLOOD, ISSN 0006-4971, 01/2006, Volume 107, Issue 1, pp. 265 - 276
Because the causes of most lymphoid neoplasms remain unknown, comparison of incidence patterns by disease subtype may provide critical clues for future... 
B-CELL LYMPHOMA | CHILDHOOD-CANCER | INCREASING INCIDENCE | DISEASE INCIDENCE | KAPOSIS-SARCOMA | ACTIVE ANTIRETROVIRAL THERAPY | NON-HODGKINS-LYMPHOMA | CHRONIC LYMPHOCYTIC-LEUKEMIA | CANCER SURVEILLANCE SERIES | HEMATOLOGY | TIME TRENDS
Journal Article
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, ISSN 1083-8791, 09/2010, Volume 16, Issue 9, pp. 1245 - 1256
Immunotherapeutic ablation of lymphoma is a conceptually attractive treatment strategy that is the subject of intense translational research. Cytotoxic T... 
Adoptive therapy | IN-VIVO PERSISTENCE | NEUROBLASTOMA | IMMUNOLOGY | TRANSPLANTATION | Cellular immunotherapy | THERAPY | MEMORY | IMMUNOTHERAPY | CD19 | Clinical trial | NON-HODGKINS-LYMPHOMA | T lymphocyte | HEMATOLOGY | CLONES | LYMPHOCYTES
Journal Article
Journal of Clinical and Diagnostic Research, ISSN 2249-782X, 12/2018, Volume 12, Issue 12, pp. ED19 - ED20
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2013, Volume 19, Issue 2, pp. 202 - 208
Journal Article
Blood, ISSN 0006-4971, 02/2002, Volume 99, Issue 3, pp. 754 - 758
Given that the FcgammaRIIIa receptor 158V allotype displays a higher affinity for human immunoglobulin G1 and increased antibody-dependent cellular... 
CD20 | RITUXIMAB | IDEC-C2B8 | B-CELL LYMPHOMAS | IN-VIVO | DISEASE | NON-HODGKINS-LYMPHOMA | PHASE-II | LOW-GRADE | HEMATOLOGY | BINDING
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 03/2007, Volume 25, Issue 7, pp. 787 - 792
Purpose Chemoradiotherapy has been considered standard treatment for patients with limited-stage aggressive lymphoma on the basis of trials conducted before... 
B-CELL LYMPHOMA | LIMITED-STAGE | MANAGEMENT | ONCOLOGY | NON-HODGKINS-LYMPHOMA | BRIEF CHEMOTHERAPY
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 26, pp. 2531 - 2544
Journal Article